BMA reverses stance on Cass review after internal reassessment

The British Medical Association (BMA) has reversed its stance on the Cass review, a major assessment of NHS gender identity services for children and young people. The organisation initially opposed the findings but now accepts the review’s conclusions after an internal reassessment. The shift follows months of debate over the report’s recommendations on youth gender care.

The Cass review, led by Dr. Hilary Cass, examined NHS gender services and found they were 'built on shaky foundations'. It highlighted a lack of strong evidence supporting medical interventions like sex hormones for under-18s. The BMA’s council had previously voted to reject the review’s 32 recommendations, calling them 'unsubstantiated'.

A new evaluation by 12 BMA members has since led to a change in position. Professor David Strain, chair of the BMA’s board of science, described the process as constructive. He noted that clinicians with differing views had engaged respectfully and thoroughly reviewed the evidence. Strain also emphasised that the underlying data and ethical challenges were treated with consistent respect. The BMA’s updated stance reflects a more measured approach to the review’s findings.

The BMA’s decision removes a key obstacle to implementing the Cass review’s recommendations. The review had warned that young patients were not receiving care based on high-quality evidence. With the BMA’s opposition withdrawn, NHS gender services may now face fewer barriers to reform.